| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
8,620 |
6,472 |
$758K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
36,794 |
26,917 |
$733K |
| J3300 |
Injection, triamcinolone acetonide, preservative free, 1 mg |
4,344 |
2,964 |
$606K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,191 |
13,075 |
$419K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
9,188 |
6,945 |
$287K |
| 77002 |
|
2,179 |
1,473 |
$50K |
| 20610 |
|
1,346 |
906 |
$42K |
| 72110 |
|
2,467 |
2,025 |
$39K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,939 |
2,162 |
$35K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
802 |
586 |
$34K |
| 71046 |
Radiologic examination, chest; 2 views |
2,280 |
1,838 |
$26K |
| 64493 |
|
665 |
379 |
$21K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,867 |
3,059 |
$18K |
| 72050 |
|
1,096 |
882 |
$17K |
| 20605 |
|
525 |
367 |
$14K |
| 20552 |
|
745 |
530 |
$14K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
352 |
290 |
$14K |
| 95943 |
|
264 |
211 |
$14K |
| 81025 |
|
3,032 |
2,209 |
$13K |
| 27096 |
|
53 |
51 |
$12K |
| 82962 |
|
7,809 |
5,283 |
$11K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
382 |
344 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,091 |
881 |
$10K |
| 94060 |
|
457 |
338 |
$10K |
| 93000 |
|
1,008 |
796 |
$10K |
| 72070 |
|
854 |
687 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
946 |
782 |
$9K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
980 |
732 |
$8K |
| 95923 |
|
264 |
211 |
$8K |
| 73562 |
|
698 |
371 |
$8K |
| 64494 |
|
665 |
378 |
$7K |
| 64495 |
|
632 |
358 |
$7K |
| 73030 |
|
475 |
298 |
$6K |
| 27370 |
|
55 |
39 |
$4K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
24 |
15 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
755 |
542 |
$3K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
17 |
17 |
$2K |
| 73580 |
|
55 |
39 |
$2K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
34 |
15 |
$2K |
| 90686 |
|
255 |
172 |
$1K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
507 |
417 |
$1K |
| 74019 |
|
92 |
81 |
$1K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
51 |
24 |
$1K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
54 |
26 |
$1K |
| 73521 |
|
64 |
55 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
257 |
177 |
$1K |
| 73130 |
|
61 |
28 |
$800.10 |
| 73502 |
|
53 |
43 |
$711.54 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
48 |
35 |
$658.28 |
| 73610 |
|
67 |
36 |
$636.97 |
| 81002 |
|
786 |
633 |
$626.09 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
92 |
77 |
$536.44 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
18 |
14 |
$498.56 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
843 |
661 |
$450.52 |
| 90714 |
|
61 |
32 |
$409.14 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
48 |
39 |
$381.99 |
| 85651 |
|
249 |
203 |
$293.22 |
| 73522 |
|
30 |
14 |
$230.74 |
| 70220 |
|
19 |
15 |
$216.60 |
| 82947 |
|
83 |
68 |
$136.90 |
| 85610 |
|
77 |
50 |
$135.87 |
| 82274 |
|
19 |
15 |
$70.30 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
12 |
$66.17 |
| 99318 |
|
35 |
34 |
$0.00 |